Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.4 USD | +1.69% | -1.84% | -8.98% |
Financials (USD)
Sales 2024 * | 710M | Sales 2025 * | 839M | Capitalization | 1.67B |
---|---|---|---|---|---|
Net income 2024 * | 136M | Net income 2025 * | 237M | EV / Sales 2024 * | 1.94 x |
Net cash position 2024 * | 292M | Net cash position 2025 * | 524M | EV / Sales 2025 * | 1.36 x |
P/E ratio 2024 * |
13.2
x | P/E ratio 2025 * |
7.54
x | Employees | 246 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 58.66% |
Latest transcript on Harmony Biosciences Holdings, Inc.
1 day | +1.69% | ||
1 week | -1.84% | ||
1 month | -7.23% | ||
3 months | -8.44% | ||
6 months | -3.54% | ||
Current year | -8.98% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Dayno
CEO | Chief Executive Officer | 66 | 17-10-31 |
Director of Finance/CFO | 54 | 21-03-28 | |
Kumar Budur
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Aronin
FOU | Founder | 56 | 17-07-24 |
R. Graf
BRD | Director/Board Member | 59 | 20-11-10 |
Andreas Wicki
BRD | Director/Board Member | 64 | 17-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.52% | 14 M€ | -4.82% | ||
0.35% | 28 M€ | -1.00% | ||
0.31% | 25 M€ | -2.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 29.4 | +1.84% | 253,519 |
24-05-30 | 28.87 | -1.57% | 298,648 |
24-05-29 | 29.33 | -0.31% | 274,574 |
24-05-28 | 29.42 | -1.77% | 241,381 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.98% | 1.67B | |
+40.73% | 739B | |
+31.61% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.45% | 240B | |
+9.49% | 210B | |
-4.91% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- HRMY Stock